Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 27

Sort by

Sort Order Select

Meeting Abstracts

721-P: Mechanisms of Relapse after Lifestyle Intervention–Induced Remission of Prediabetes

Diabetes 2024;73(Supplement_1):721-P

https://doi.org/10.2337/db24-721-P

Published: 14 June 2024

View article titled, 721-P: Mechanisms of Relapse after Lifestyle Intervention–Induced Remission of Prediabetes

Meeting Abstracts

71-OR: Rates of Remission and Metabolic Responses in Data-Driven High-Risk Prediabetes Clusters

Diabetes 2024;73(Supplement_1):71-OR

https://doi.org/10.2337/db24-71-OR

Published: 14 June 2024

View article titled, 71-OR: Rates of Remission and Metabolic Responses in Data-Driven High-Risk Prediabetes Clusters

Meeting Abstracts

72-OR: Mechanisms of Prediabetes Remission in People with Weight Gain after Lifestyle Intervention

Diabetes 2024;73(Supplement_1):72-OR

https://doi.org/10.2337/db24-72-OR

Published: 14 June 2024

View article titled, 72-OR: Mechanisms of Prediabetes Remission in People with Weight Gain after Lifestyle Intervention

Meeting Abstracts

96-OR: Liver Fibrosis Scores in Novel Subclusters of Patients at Risk for Type 2 Diabetes

VITORIA MINELLI FAIAO, ARVID SANDFORTH, SARAH KATZENSTEIN, ANDREAS FRITSCHE, LOUISE FRITSCHE, JÜRGEN MACHANN, FRITZ SCHICK, HANS-ULRICH HÄRING, ROBERT WAGNER, ANDREAS PETER, ANDREAS L. BIRKENFELD, NORBERT STEFAN, REINER JUMPERTZ VON SCHWARTZENBERG

Diabetes 2023;72(Supplement_1):96-OR

https://doi.org/10.2337/db23-96-OR

Published: 20 June 2023

View article titled, 96-OR: Liver Fibrosis Scores in Novel Subclusters of Patients at Risk for Type 2 Diabetes

Journal Articles

Lower Hepatic Fat Is Associated With Improved Insulin Secretion in a High-Risk Prediabetes Subphenotype During Lifestyle Intervention

Diabetes 2023;72(3):362–366

https://doi.org/10.2337/db22-0441

Published: 16 December 2022

View article titled, Lower Hepatic Fat Is Associated With Improved Insulin Secretion in a High-Risk Prediabetes Subphenotype During Lifestyle Intervention

Journal Articles

Fat Distribution Patterns and Future Type 2 Diabetes

Hajime Yamazaki, Shinichi Tauchi, Jürgen Machann, Tobias Haueise, Yosuke Yamamoto, Mitsuru Dohke, Nagisa Hanawa, Yoshihisa Kodama, Akio Katanuma, Norbert Stefan, Andreas Fritsche, Andreas L. Birkenfeld, Róbert Wagner, Martin Heni

Diabetes 2022;71(9):1937–1945

https://doi.org/10.2337/db22-0315

Published: 20 June 2022

View article titled, Fat Distribution Patterns and Future Type 2 Diabetes

Meeting Abstracts

180-OR: Empagliflozin Does Not Affect Pancreatic Fat Content and Insulin Secretion in Humans with Prediabetes

JULIA HUMMEL, JÜRGEN MACHANN, CORINNA DANNECKER, STEPHANIE KULLMANN, ANDREAS L. BIRKENFELD, HANS-ULRICH HÄRING, ANDREAS PETER, ANDREAS FRITSCHE, ROBERT WAGNER, MARTIN HENI

Diabetes 2022;71(Supplement_1):180-OR

https://doi.org/10.2337/db22-180-OR

Published: 01 June 2022

View article titled, 180-OR: Empagliflozin Does Not Affect Pancreatic Fat Content and Insulin Secretion in Humans with Prediabetes

Meeting Abstracts

118-OR: Fat Distribution Patterns Predict Type 2 Diabetes Risk and Provide Insights into Prediabetic Metabolism

HAJIME YAMAZAKI, SHIN-ICHI TAUCHI, JÜRGEN MACHANN, TOBIAS HAUEISE, YOSUKE YAMAMOTO, MITSURU DOHKE, NAGISA HANAWA, YOSHIHISA KODAMA, AKIO KATANUMA, NORBERT STEFAN, ANDREAS FRITSCHE, ANDREAS L. BIRKENFELD, ROBERT WAGNER, MARTIN HENI

Diabetes 2022;71(Supplement_1):118-OR

https://doi.org/10.2337/db22-118-OR

Published: 01 June 2022

View article titled, 118-OR: Fat Distribution Patterns Predict Type 2 Diabetes Risk and Provide Insights into Prediabetic Metabolism

Journal Articles

Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS)

Diabetes 2021;70(12):2785–2795

https://doi.org/10.2337/db21-0526

Published: 16 September 2021

View article titled, Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS)

Meeting Abstracts

102-OR: Detection of Diabetes from Whole-Body Magnetic Resonance Imaging Using Deep Learning

ROBERT WAGNER, BENEDIKT DIETZ, JÜRGEN MACHANN, PATRICK SCHWAB, JULIA K. DIENES, STEFFEN REICHERT, ANDREAS L. BIRKENFELD, HANS-ULRICH HAERING, FRITZ SCHICK, NORBERT STEFAN, MARTIN HENI, HUBERT PREISSL, BERNHARD SCHÖLKOPF, STEFAN BAUER, ANDREAS FRITSCHE

Diabetes 2020;69(Supplement_1):102-OR

https://doi.org/10.2337/db20-102-OR

Published: 01 June 2020

View article titled, 102-OR: Detection of Diabetes from Whole-Body Magnetic Resonance Imaging Using Deep Learning

Meeting Abstracts

1856-P: Hepatic Insulin Clearance Is Not Driven by Liver Fat but by Systemic Inflammation: A Mendelian Randomization Study

APOSTOLIA LAMPRINOU, JÜRGEN MACHANN, FRITZ SCHICK, SABINE S. ECKSTEIN, CHIARA DALLA MAN, ROBERTO VISENTIN, NORBERT STEFAN, ANDREAS L. BIRKENFELD, ANDREAS PETER, HANS-ULRICH HAERING, ANDREAS FRITSCHE, MARTIN HENI, ROBERT WAGNER

Diabetes 2020;69(Supplement_1):1856-P

https://doi.org/10.2337/db20-1856-P

Published: 01 June 2020

View article titled, 1856-P: Hepatic Insulin Clearance Is Not Driven by Liver Fat but by Systemic Inflammation: A Mendelian Randomization Study

Meeting Abstracts

148-OR: Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans with Prediabetes

MARTIN HENI, STEPHANIE KULLMANN, ROBERT WAGNER, JULIA HUMMEL, CORINNA DANNECKER, ANDREAS VOSSELER, LOUISE FRITSCHE, KONSTANTINOS KANTARTZIS, JÜRGEN MACHANN, HANS-ULRICH HAERING, ANDREAS FRITSCHE, HUBERT PREISSL

Diabetes 2020;69(Supplement_1):148-OR

https://doi.org/10.2337/db20-148-OR

Published: 01 June 2020

View article titled, 148-OR: Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans with Prediabetes

Meeting Abstracts

1099-P: Effects of Empagliflozin on Glucose Metabolism and Body Fat Composition in Patients with Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

JULIA HUMMEL, CORINNA DANNECKER, LOUISE FRITSCHE, ANDREAS VOSSELER, KONSTANTINOS KANTARTZIS, STEPHANIE KULLMANN, JÜRGEN MACHANN, HUBERT PREISSL, HANS-ULRICH HAERING, ANDREAS FRITSCHE, ROBERT WAGNER, MARTIN HENI

Diabetes 2020;69(Supplement_1):1099-P

https://doi.org/10.2337/db20-1099-P

Published: 01 June 2020

View article titled, 1099-P: Effects of Empagliflozin on Glucose Metabolism and Body Fat Composition in Patients with Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

Meeting Abstracts

1834-P: Pancreatic Fat Associates with Impaired Insulin Secretion in Genetically Predisposed Individuals

BENJAMIN JAGHUTRIZ, MARTIN HENI, JÜRGEN MACHANN, FRITZ SCHICK, SUSANNE ULLRICH, HANS-ULRICH HAERING, ANDREAS FRITSCHE, ROBERT WAGNER

Diabetes 2019;68(Supplement_1):1834-P

https://doi.org/10.2337/db19-1834-P

Published: 01 June 2019

View article titled, 1834-P: Pancreatic Fat Associates with Impaired Insulin Secretion in Genetically Predisposed Individuals

Meeting Abstracts

133-OR: Effects of Empagliflozin on Liver Fat Content in Type 2 Diabetes: The EMLIFA001 Trial

SABINE KAHL, SOFIYA GANCHEVA, KLAUS STRASSBURGER, CHRISTIAN HERDER, JÜRGEN MACHANN, HISAYUKI KATSUYAMA, STEFAN KABISCH, ELENA HENKEL, STEFAN KOPF, KONSTANTINOS KANTARTZIS, YULIYA KUPRIYANOVA, OLIVER KUSS, JONG-HEE HWANG, CHRISTIAN KASPERK, NORBERT STEFAN, ANDREAS F. PFEIFFER, ANDREAS L. BIRKENFELD, MICHAEL RODEN

Diabetes 2019;68(Supplement_1):133-OR

https://doi.org/10.2337/db19-133-OR

Published: 01 June 2019

View article titled, 133-OR: Effects of Empagliflozin on Liver Fat Content in Type 2 Diabetes: The EMLIFA001 Trial

Journal Articles

Genome-Wide and Abdominal MRI Data Provide Evidence That a Genetically Determined Favorable Adiposity Phenotype Is Characterized by Lower Ectopic Liver Fat and Lower Risk of Type 2 Diabetes, Heart Disease, and Hypertension

Diabetes 2019;68(1):207–219

https://doi.org/10.2337/db18-0708

Published: 23 October 2018

View article titled, Genome-Wide and Abdominal MRI Data Provide Evidence That a Genetically Determined Favorable Adiposity Phenotype Is Characterized by Lower Ectopic Liver Fat and Lower Risk of Type 2 Diabetes, Heart Disease, and Hypertension

Includes: Supplementary data

Meeting Abstracts

Association of Pancreas Fat with Impaired Insulin Secretion Depends on Liver Fat and Circulating Fatty Acids

BENJAMIN JAGHUTRIZ, ROBERT WAGNER, JÜRGEN MACHANN, NORBERT STEFAN, ANDREAS PETER, DOROTHEA I. SIEGEL-AXEL, FELICIA GERST, SUSANNE ULLRICH, ANDREAS FRITSCHE, HANS-ULRICH HAERING, MARTIN HENI

Diabetes 2018;67(Supplement_1):1819-P

https://doi.org/10.2337/db18-1819-P

Published: 01 July 2018

View article titled, Association of Pancreas Fat with Impaired Insulin Secretion Depends on Liver Fat and Circulating Fatty Acids

Meeting Abstracts

Brain Insulin Sensitivity Predicts Adiposity—Nine-Year Results of the Tulip Study

VERA SCHMID, OTTO TSCHRITTER, JÜRGEN MACHANN, ROBERT WAGNER, NORBERT STEFAN, HUBERT PREISSL, HANS-ULRICH HAERING, ANDREAS FRITSCHE, MARTIN HENI

Diabetes 2018;67(Supplement_1):364-OR

https://doi.org/10.2337/db18-364-OR

Published: 01 July 2018

View article titled, Brain Insulin Sensitivity Predicts Adiposity—Nine-Year Results of the Tulip Study

Journal Articles

Nonsuppressed Glucagon After Glucose Challenge as a Potential Predictor for Glucose Tolerance

Róbert Wagner, Liisa H. Hakaste, Emma Ahlqvist, Martin Heni, Jürgen Machann, Fritz Schick, Emmanuel Van Obberghen, Norbert Stefan, Baptist Gallwitz, Tiinamaija Tuomi, Hans-Ulrich Häring, Leif Groop, Andreas Fritsche

Diabetes 2017;66(5):1373–1379

https://doi.org/10.2337/db16-0354

Published: 16 December 2016

View article titled, Nonsuppressed Glucagon After Glucose Challenge as a Potential Predictor for Glucose Tolerance

Includes: Supplementary data

Journal Articles

Subclinical Disease Burden as Assessed by Whole-Body MRI in Subjects With Prediabetes, Subjects With Diabetes, and Normal Control Subjects From the General Population: The KORA-MRI Study

Diabetes 2017;66(1):158–169

https://doi.org/10.2337/db16-0630

Published: 10 October 2016

View article titled, Subclinical Disease Burden as Assessed by Whole-Body MRI in Subjects With Prediabetes, Subjects With Diabetes, and Normal Control Subjects From the General Population: The KORA-MRI Study

Includes: Supplementary data

NARROW

721-P: Mechanisms of Relapse after Lifestyle Intervention–Induced Remission of Prediabetes

71-OR: Rates of Remission and Metabolic Responses in Data-Driven High-Risk Prediabetes Clusters

72-OR: Mechanisms of Prediabetes Remission in People with Weight Gain after Lifestyle Intervention

96-OR: Liver Fibrosis Scores in Novel Subclusters of Patients at Risk for Type 2 Diabetes

Lower Hepatic Fat Is Associated With Improved Insulin Secretion in a High-Risk Prediabetes Subphenotype During Lifestyle Intervention

Fat Distribution Patterns and Future Type 2 Diabetes

180-OR: Empagliflozin Does Not Affect Pancreatic Fat Content and Insulin Secretion in Humans with Prediabetes

118-OR: Fat Distribution Patterns Predict Type 2 Diabetes Risk and Provide Insights into Prediabetic Metabolism

Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS)

102-OR: Detection of Diabetes from Whole-Body Magnetic Resonance Imaging Using Deep Learning

1856-P: Hepatic Insulin Clearance Is Not Driven by Liver Fat but by Systemic Inflammation: A Mendelian Randomization Study

148-OR: Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans with Prediabetes

1099-P: Effects of Empagliflozin on Glucose Metabolism and Body Fat Composition in Patients with Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

1834-P: Pancreatic Fat Associates with Impaired Insulin Secretion in Genetically Predisposed Individuals

133-OR: Effects of Empagliflozin on Liver Fat Content in Type 2 Diabetes: The EMLIFA001 Trial

Genome-Wide and Abdominal MRI Data Provide Evidence That a Genetically Determined Favorable Adiposity Phenotype Is Characterized by Lower Ectopic Liver Fat and Lower Risk of Type 2 Diabetes, Heart Disease, and Hypertension

Association of Pancreas Fat with Impaired Insulin Secretion Depends on Liver Fat and Circulating Fatty Acids

Brain Insulin Sensitivity Predicts Adiposity—Nine-Year Results of the Tulip Study

Nonsuppressed Glucagon After Glucose Challenge as a Potential Predictor for Glucose Tolerance

Subclinical Disease Burden as Assessed by Whole-Body MRI in Subjects With Prediabetes, Subjects With Diabetes, and Normal Control Subjects From the General Population: The KORA-MRI Study

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only